1 Min Read
May 29 (Reuters) - Genscript Biotech Corp
* application for clinical trial on KLT-1101 was accepted by China food and drug administration on 4 May 2017. Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.